U.S. Industrial REITs Stock News

Cigna Group (CI) stock is in focus after the company reported first quarter results that topped prior year revenue and earnings, and outlined plans to exit subsidized Affordable Care Act plans. See our latest analysis for Cigna Group. The first quarter beat and ACA exit plan come after a mixed period for the stock, with a 3.57% 1 month share price return but a 12.93% 1 year total shareholder return decline. This suggests recent momentum is improving from a weaker longer term picture. If this...

Dutch Bros Inc. reported past first-quarter 2026 results with revenue of US$464.41 million, net income of US$16.1 million, and flat GAAP earnings per share of US$0.13, while opening 41 new shops and lifting full-year guidance across key financial and operational metrics. The company’s willingness to raise its outlook after strong same-shop sales and transaction growth underscores management’s confidence in its rapid, company-operated expansion model and emerging food and digital...

Lumentum Holdings (NasdaqGS:LITE) is set to join the Nasdaq-100 Index. The addition recognizes the company as one of the larger non financial technology stocks in the U.S. market. Lumentum Holdings, trading under NasdaqGS:LITE, is drawing fresh attention as it prepares to enter the Nasdaq-100 Index. The move comes with the stock around $892.79 and follows very large gains over the past year and the past three years, as well as a 131.2% return year to date. Over the past month, the stock...

Recent Performance Snapshot EPR Properties (EPR) has drawn fresh attention after a period of positive share performance, with the stock up 2.8% over the past day, 3.7% over the past week, and 10.6% over the past month. See our latest analysis for EPR Properties. At a share price of $57.88, the stock has recently picked up momentum, with a 1 month share price return of 10.65% supporting an already strong 1 year total shareholder return of 19.66% and 3 year total shareholder return of...

Sana Biotechnology (SANA) is back in focus as CEO Steve Harr prepares to deliver a business overview and company update at the BofA Securities 2026 Healthcare Conference on May 12. See our latest analysis for Sana Biotechnology. At a share price of $3.50, Sana’s 7 day share price return of 6.38% and 30 day share price return of 11.11% contrast with a year to date share price decline of 16.47%. The 1 year total shareholder return of 93.37% sits against weaker 3 and 5 year total shareholder...

In recent weeks, Amer Sports has delivered a run of earnings and revenue beats, outpacing analyst expectations and highlighting especially strong momentum in its premium outdoor brands such as Arc’teryx. What stands out is how Arc’teryx’s expansion into new regions and lifestyle categories is becoming a central engine for Amer Sports’ growth ambitions and margin improvement plans. We’ll now examine how Amer Sports’ consistent earnings outperformance and Arc’teryx-led expansion could...

In late April 2026, FormFactor, Inc. reported first-quarter revenue of US$226.14 million and net income of US$20.38 million, and issued second-quarter guidance calling for revenue around US$240 million and net income per diluted share near US$0.46, alongside expectations for record quarterly revenue and higher margins. Management linked this momentum to strong demand for AI-related semiconductor testing and ongoing restructuring and capacity investments, while FormFactor also highlighted its...

If you are looking at Goosehead Insurance and wondering whether the recent share price puts the stock on sale or still leaves it looking expensive, the starting point is to understand how its current valuation stacks up against its fundamentals. The stock last closed at US$42.12, after recent returns of a 6.0% decline over 7 days, a 5.7% decline over 30 days, a 40.0% decline year to date, and a 58.8% decline over the past year. This naturally raises questions about whether sentiment has...

If you are wondering whether Asana’s current share price reflects its true worth, this breakdown will help you weigh what the market is pricing in against what the fundamentals suggest. Asana’s stock last closed at US$7.05, with a 7 day return of 11.6% and a 30 day return of 13.7%. However, the year to date return of negative 45.6% and 1 year return of negative 59.1% highlight that many holders have faced a tough ride. Those recent moves sit against a backdrop of ongoing coverage around...

Raymond James Financial (NYSE:RJF) has rolled out its Client 360 platform and an artificial intelligence learning academy for financial advisors. The company is committing a reported US$1.1b to technology, including AI powered tools aimed at improving advisor productivity and client service. Raymond James has closed its acquisition of Clark Capital Management Group and introduced proprietary active ETFs to expand its asset management menu. For investors following wealth management and...

Harley-Davidson (HOG) has put its Q1 2026 earnings and new Back to the Bricks plan front and center, pairing softer profit with stronger-than-expected revenue, double-digit North American retail growth, and reaffirmed full year guidance. See our latest analysis for Harley-Davidson. The stock has gained momentum recently, with a 30 day share price return of 11.61% and a 90 day share price return of 15.37%, while the 5 year total shareholder return of a 43.30% decline points to a tougher longer...

What recent performance says about Signet Jewelers (SIG) Without a specific news headline driving the move, Signet Jewelers (SIG) has attracted interest after a period where the stock showed a mix of short term pullbacks and longer term gains. See our latest analysis for Signet Jewelers. At a share price of $87.99, Signet’s recent 1 day and 30 day share price gains contrast with a weaker 90 day share price return. However, the 1 year total shareholder return of 37.84% and 5 year total...

Kodiak Sciences (NasdaqGM:KOD) reported positive Phase 3 GLOW2 results for Zenkuda (tarcocimab tedromer) in diabetic retinopathy. The drug showed superiority over sham treatment, supporting a potential multi indication BLA submission. The update follows earlier focus on KSI-101 and adds fresh validation for Kodiak’s ABC platform in retinal disease. Kodiak Sciences, trading at $43.68, now has clinically meaningful Phase 3 data for Zenkuda that relates directly to its lead pipeline asset. The...

Zoetis (ZTS) has opened 2026 with Q1 revenue of US$2.3b and basic EPS of US$1.42, setting the tone for how investors read the latest earnings update. The company has seen quarterly revenue move from US$2.2b in Q1 2025 to US$2.3b in Q1 2026, while basic EPS shifted from US$1.41 to US$1.42 over the same period, giving you a clear view of how the top and bottom lines are tracking year on year. Against that backdrop, the focus now is on how sustainably Zoetis is converting this revenue into...

In the first quarter ended March 31, 2026, Victory Capital Holdings reported revenue of US$387.99 million and net income of US$112.14 million, with basic earnings per share from continuing operations of US$1.34, and also declared a quarterly dividend of US$0.50 per share payable on June 25, 2026. The combination of sharply higher revenue and earnings compared with a year earlier and a higher cash return through the US$0.50 dividend signals both improved profitability and a willingness to...

Sensient Technologies recently reported stronger Q1 2026 results, driven by higher volumes, favorable foreign exchange, and pricing, while completing its Portfolio Optimization Plan expected to cut annual operating costs by about US$8,000,000 and issuing €65,000,000 in senior notes to refinance revolving credit borrowings. Alongside these operating gains, fresh performance-based stock unit grants tied to EBITDA growth, return on invested capital, and revenue highlight how management...

If you are wondering whether Royal Gold's current share price reflects its underlying value, this article walks through the key numbers that can help you form an informed view. The stock closed at US$232.62, with returns of 5.2% year to date and 31.3% over 1 year, while the last 30 days show a 10.8% decline and the last 7 days a 0.3% decline. Recent coverage has focused on Royal Gold's long term share price performance and how it compares with the broader materials sector. This helps frame...

Healthpeak Properties (DOC) recently reported better than expected first quarter 2026 results, raised full year earnings guidance and completed the Janus Living IPO, moves that appear central to the latest stock reaction. See our latest analysis for Healthpeak Properties. The stock’s recent move appears to reflect a reset in sentiment, with a 7 day share price return of 21.58% and year to date share price return of 21.36%, while the 5 year total shareholder return of a 21.10% decline shows...

Why Playtika Holding (PLTK) is on investors’ radar Playtika Holding (PLTK) has seen its stock move in recent months, with a roughly 14% gain over the past month and a modest rise over the past 3 months catching investors’ attention. See our latest analysis for Playtika Holding. That short term momentum, with a 30 day share price return of 14.4%, sits against weaker longer term performance. This includes a year to date share price decline of 9.7% and a 1 year total shareholder return of 22.8%...

Sensata Technologies Holding plc has reported past first-quarter 2026 results showing sales of US$934.8 million and net income of US$87.1 million, alongside new second-quarter guidance and an update on its ongoing share repurchase program. Together, the stronger quarterly earnings, forward earnings guidance, and completion of a multi-year buyback provide fresh insight into how Sensata is balancing growth investment with returning capital to shareholders. Next, we will examine how Sensata’s...

Investors may be wondering whether AST SpaceMobile’s recent share price still leaves room for value, or if the stock has already run ahead of itself. The stock last closed at US$65.35, with a 1 year return of 158.8% and a very large 3 year gain. Over the shorter term, the 30 day return of a 29.4% decline and 7 day return of an 11.6% decline show sharp pullbacks that can change how investors think about risk and reward. Recent coverage has focused on AST SpaceMobile’s ambitious aim to build a...

In late April 2026, Bloom Energy reported Q1 2026 revenue of US$751.05 million, a move to net income of US$70.65 million, and raised its full-year 2026 revenue outlook to US$3.4–3.8 billion after Oracle and BorderPlex Digital Assets selected its fuel cells to fully power the Project Jupiter AI data center campus in New Mexico. This combination of a large, multi-gigawatt Oracle fuel cell agreement and a swing to profitability highlights how AI data center power demand is reshaping Bloom...

Arcus Biosciences (RCUS) has been in focus after first quarter 2026 results, which showed revenue of US$17 million and a net loss of US$128 million, alongside several pipeline and collaboration setbacks. See our latest analysis for Arcus Biosciences. The share price has been volatile around the recent Q1 2026 update and pipeline news. The 1 month share price return is 12.28% and the 90 day share price return is 17.83%, while the 1 year total shareholder return of 190.50% contrasts with a...

Artificial intelligence in healthcare sits at the crossroads of powerful data, rising care costs, and a world focused on inflation, energy shocks, and supply chain shifts. While oil, rates, and trade headlines pull markets in different directions, AI tools that can improve accuracy, access, and affordability in medicine are drawing close attention. The Transformative AI Healthcare Stocks screener looks for companies using AI to sharpen diagnostics, personalise treatment, streamline clinical...